(Q34619948)

3 August 2017

1 reference

title

Development of a DNA-MVA/HIVA vaccine for Kenya (English)

1 reference

3 August 2017

0 references

1 reference

Andrew James McMichael

2

object named as

Andrew J McMichael

1 reference

3 August 2017

Tomás Hanke

1

1 reference

3 August 2017

Matilu Mwau

3

1 reference

3 August 2017

Edmund G-T Wee

4

1 reference

3 August 2017

Inese Ceberej

5

1 reference

3 August 2017

Sandip Patel

6

1 reference

3 August 2017

Julian Sutton

7

1 reference

3 August 2017

Maxine Tomlinson

8

1 reference

3 August 2017

Rachel V Samuel

9

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

20

1 reference

3 August 2017

issue

15

1 reference

3 August 2017

page(s)

1995-1998

1 reference

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Human immunodeficiency virus type 1 (HIV-1)-specific T cell responses correlate with control of acute HIV-1 infection in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Functional genomics Double-stranded RNA poses puzzle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Characterization of HIV-1-specific T-helper cells in acute and chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900085-3

7 January 2021

10.1016/S0264-410X(02)00085-3

Identifiers

DOI

1 reference

3 August 2017

1 reference